KLA Corp. vs Vir Biotechnology Inc. Common Stock — how do they compare? KLA Corp. trades at $173.88 (market cap $240.12B), while Vir Biotechnology Inc. Common Stock trades at $10.2 (market cap $1.80B). The key difference: KLA Corp. is far larger — about 133.4× Vir Biotechnology Inc. Common Stock's market cap, and KLA Corp. pays a 0.5% dividend while Vir Biotechnology Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold KLA Corp. for 60 Days and Vir Biotechnology Inc. Common Stock for 0 Days on average.
| KLAC | VIR | |
|---|---|---|
Market Cap | $240.12B | $1.80B |
Volume | 10,439,404 | 1,782,836 |
Sector | Technology | Health |
52-Week High | $301.71 | $11.78 |
52-Week Low | $108.70 | $5.12 |
Typical Hold Time | 60 Days | 0 Days |
Enterprise Value | $241.37B | $1.36B |
Dividend Yield | 0.5% | — |
Signals from Pluang's Aura AI — not financial advice
KLA Corporation (KLAC) trades at $178.81, down 5.95% on the day, amid a broader tech selloff. The stock maintains a bullish technical signal, with strong fundamentals including a 35.57% net income margin and consistent earnings beats. Revenue reached $12.16B in 2025, with a robust backlog of $12.57B driven by AI demand, positioning the company for growth in semiconductor equipment.
The outlook remains positive with a consensus price target of $223.88, implying significant upside. Risks include competitive pressures from Applied Materials and ASML, and sensitivity to semiconductor capex cycles. Analyst sentiment is strongly bullish, with 28 buy ratings, supporting a favorable long-term investment case despite near-term volatility.
No Aura AI signal available yet.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
KLA designs and manufactures yield-management and process-monitoring diagnostic and control systems for the semiconductor manufacturing industry. The systems are used to analyze the manufacturing process at various steps in a semiconductor's development. The firm's laser-scanning products are used for wafer qualification, process monitoring, and equipment monitoring. KLA also provides inspection tools and systems for optical metrology and e-beam metrology.
Read more on KLAC →Vir Biotechnology, Inc. is a US clinical-stage biopharmaceutical company that develops monoclonal antibody-based medicines to treat and prevent serious infectious diseases.
Read more on VIR →